Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03616821 · TERMINATED
Trial details
- NCT number
- NCT03616821
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-07
- Primary completion
- 2023-10-23
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.